These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 16857742

  • 1. Ras-dependent recruitment of c-Myc for transcriptional activation of nucleophosmin/B23 in highly malignant U1 bladder cancer cells.
    Yeh CW, Huang SS, Lee RP, Yung BY.
    Mol Pharmacol; 2006 Oct; 70(4):1443-53. PubMed ID: 16857742
    [Abstract] [Full Text] [Related]

  • 2. Nucleophosmin/B23 regulates transcriptional activation of E2F1 via modulating the promoter binding of NF-kappaB, E2F1 and pRB.
    Lin CY, Liang YC, Yung BY.
    Cell Signal; 2006 Nov; 18(11):2041-8. PubMed ID: 16725311
    [Abstract] [Full Text] [Related]

  • 3. Nucleophosmin/B23-binding peptide inhibits tumor growth and up-regulates transcriptional activity of p53.
    Chan HJ, Weng JJ, Yung BY.
    Biochem Biophys Res Commun; 2005 Jul 29; 333(2):396-403. PubMed ID: 15950182
    [Abstract] [Full Text] [Related]

  • 4. Growth factor-dependent regulation of survivin by c-myc in human breast cancer.
    Cosgrave N, Hill AD, Young LS.
    J Mol Endocrinol; 2006 Dec 29; 37(3):377-90. PubMed ID: 17170079
    [Abstract] [Full Text] [Related]

  • 5. Oncogenic role of nucleophosmin/B23.
    Yung BY.
    Chang Gung Med J; 2007 Dec 29; 30(4):285-93. PubMed ID: 17939258
    [Abstract] [Full Text] [Related]

  • 6. c-Myc inhibits Ras-mediated differentiation of pheochromocytoma cells by blocking c-Jun up-regulation.
    Vaqué JP, Fernández-García B, García-Sanz P, Ferrandiz N, Bretones G, Calvo F, Crespo P, Marín MC, León J.
    Mol Cancer Res; 2008 Feb 29; 6(2):325-39. PubMed ID: 18314492
    [Abstract] [Full Text] [Related]

  • 7. The tumor suppressor KLF11 mediates a novel mechanism in transforming growth factor beta-induced growth inhibition that is inactivated in pancreatic cancer.
    Buck A, Buchholz M, Wagner M, Adler G, Gress T, Ellenrieder V.
    Mol Cancer Res; 2006 Nov 29; 4(11):861-72. PubMed ID: 17114344
    [Abstract] [Full Text] [Related]

  • 8. c-Myc-mediated expression of nucleophosmin/B23 decreases during retinoic acid-induced differentiation of human leukemia HL-60 cells.
    Yung BY.
    FEBS Lett; 2004 Dec 17; 578(3):211-6. PubMed ID: 15589822
    [Abstract] [Full Text] [Related]

  • 9. Association of nucleophosmin/B23 with bladder cancer recurrence based on immunohistochemical assessment in clinical samples.
    Tsui KH, Juang HH, Lee TH, Chang PL, Chen CL, Yung BY.
    Acta Pharmacol Sin; 2008 Mar 17; 29(3):364-70. PubMed ID: 18298902
    [Abstract] [Full Text] [Related]

  • 10. Nucleophosmin/B23 regulates PCNA promoter through YY1.
    Weng JJ, Yung BY.
    Biochem Biophys Res Commun; 2005 Sep 30; 335(3):826-31. PubMed ID: 16099430
    [Abstract] [Full Text] [Related]

  • 11. c-Myc creates an activation loop by transcriptionally repressing its own functional inhibitor, hMad4, in young fibroblasts, a loop lost in replicatively senescent fibroblasts.
    Marcotte R, Chen JM, Huard S, Wang E.
    J Cell Biochem; 2005 Dec 01; 96(5):1071-85. PubMed ID: 16167342
    [Abstract] [Full Text] [Related]

  • 12. Adenovirus E1A oncoprotein liberates c-Myc activity to promote cell proliferation through abating Bin1 expression via an Rb/E2F1-dependent mechanism.
    Kinney EL, Tanida S, Rodrigue AA, Johnson JK, Tompkins VS, Sakamuro D.
    J Cell Physiol; 2008 Sep 01; 216(3):621-31. PubMed ID: 18348166
    [Abstract] [Full Text] [Related]

  • 13. Bin1 functionally interacts with Myc and inhibits cell proliferation via multiple mechanisms.
    Elliott K, Sakamuro D, Basu A, Du W, Wunner W, Staller P, Gaubatz S, Zhang H, Prochownik E, Eilers M, Prendergast GC.
    Oncogene; 1999 Jun 17; 18(24):3564-73. PubMed ID: 10380878
    [Abstract] [Full Text] [Related]

  • 14. Down-regulation of nucleophosmin/B23 during retinoic acid-induced differentiation of human promyelocytic leukemia HL-60 cells.
    Hsu CY, Yung BY.
    Oncogene; 1998 Feb 19; 16(7):915-23. PubMed ID: 9484783
    [Abstract] [Full Text] [Related]

  • 15. Mortalization of human promyelocytic leukemia HL-60 cells to be more susceptible to sodium butyrate-induced apoptosis and inhibition of telomerase activity by down-regulation of nucleophosmin/B23.
    Liu WH, Yung BY.
    Oncogene; 1998 Dec 10; 17(23):3055-64. PubMed ID: 9881708
    [Abstract] [Full Text] [Related]

  • 16. A novel factor distinct from E2F mediates C-MYC promoter activation through its E2F element during exit from quiescence.
    Alvaro-Blanco J, Martínez-Gac L, Calonge E, Rodríguez-Martínez M, Molina-Privado I, Redondo JM, Alcamí J, Flemington EK, Campanero MR.
    Carcinogenesis; 2009 Mar 10; 30(3):440-8. PubMed ID: 19126644
    [Abstract] [Full Text] [Related]

  • 17. Down-regulation of c-Myc following MEK/ERK inhibition halts the expression of malignant phenotype in rhabdomyosarcoma and in non muscle-derived human tumors.
    Marampon F, Ciccarelli C, Zani BM.
    Mol Cancer; 2006 Aug 09; 5():31. PubMed ID: 16899113
    [Abstract] [Full Text] [Related]

  • 18. G-rich oligonucleotide inhibits the binding of a nuclear protein to the Ki-ras promoter and strongly reduces cell growth in human carcinoma pancreatic cells.
    Cogoi S, Quadrifoglio F, Xodo LE.
    Biochemistry; 2004 Mar 09; 43(9):2512-23. PubMed ID: 14992588
    [Abstract] [Full Text] [Related]

  • 19. MAP kinase additively activates the mouse Per1 gene promoter with CaM kinase II.
    Nomura K, Takeuchi Y, Fukunaga K.
    Brain Res; 2006 Nov 06; 1118(1):25-33. PubMed ID: 17020748
    [Abstract] [Full Text] [Related]

  • 20. TATA box-binding protein-associated factor 12 is important for RAS-induced transformation properties of colorectal cancer cells.
    Voulgari A, Voskou S, Tora L, Davidson I, Sasazuki T, Shirasawa S, Pintzas A.
    Mol Cancer Res; 2008 Jun 06; 6(6):1071-83. PubMed ID: 18567809
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.